Berkshire, United Kingdom

Andrew James Ledgard

USPTO Granted Patents = 3 

Average Co-Inventor Count = 1.4

ph-index = 1


Location History:

  • Berkshire, DE (2012)
  • Berkshire, GB (2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew James Ledgard

Introduction

Andrew James Ledgard is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of pharmacology, particularly in the development of dual receptor antagonists. With a total of 3 patents to his name, Ledgard's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among his latest patents, Ledgard has developed a dual H1 inverse agonist/5-HT receptor antagonist. This invention includes a detailed description of its formula, uses, and methods for its preparation. Additionally, he has created a dual H1/5-HT receptor antagonist, which also outlines its formula, uses, and preparation methods. These innovations reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Andrew James Ledgard is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Ledgard has worked alongside esteemed colleagues such as Anne Marie Camp and Peter Thaddeus Gallagher. Their combined expertise fosters an environment of innovation and creativity, leading to the development of new therapeutic solutions.

Conclusion

In summary, Andrew James Ledgard is a distinguished inventor whose work in pharmacology has led to the creation of valuable patents. His contributions continue to shape the future of medical treatments and enhance the quality of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…